Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

AKCEA THERAPEUTICS, INC. (AKCA) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $18.13 Metrics
OS: 101.6 M -9 % ROE
Market cap: $1.84 B -16 % ROIC
Net cash: $390 M $3.84 per share
EV: $1.45 B

 
TTM Valuation
EBITDA ($39.1) M
EBIT ($45.8) M
EPS ($0.39)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues488.564.943.40.00.00.0
            Revenue growth653.1%49.5%    
Cost of goods sold5.72.70.00.00.00.0
Gross profit482.962.243.40.00.00.0
            Gross margin98.8%95.8%100.0%   
Selling, general and administrative181.7153.637.015.1  
Research and development292.9130.3126.968.550.929.0
General and administrative    10.61.0
EBITA43.9-227.9-120.4-83.4-61.3-30.0
            EBITA margin9.0%-351.4%-277.3%   
Amortization of intangibles5.92.90.10.10.1 
EBIT38.1-230.8-120.5-83.5-61.4-30.0
            EBIT margin7.8%-355.8%-277.6%   
Pre-tax income43.0-225.4-120.3-83.2-61.4-30.0
Income taxes2.20.41.30.00.00.0
            Tax rate5.1%  0.0%0.0%0.0%
Net income40.8-225.8-121.6-83.2-61.4-30.0
            Net margin8.3%-348.1%-280.1%   
 
Diluted EPS$0.43($2.78)($4.02)($1.44)($2.13) 
Shares outstanding (diluted)95.481.430.357.828.9 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy